Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

At Last: Vertex Strikes CF Deal In England

Oct 24 2019

• By Francesca Bruce

Handshake of businessmen — NHS England And Vertex Have Finally Agreed An Access Deal For Orkambi

Related Content

Vertex Commits To Novel Reimbursement Plan For Orkambi In UK, Despite Setback

Mar 22 2018

RWD Key To Scottish Orkambi Deal

Sep 12 2019

Vertex Strikes Spanish Payment-For-Results CF Deal

Oct 22 2019

Novel Procurement Deal To Rid England Of Hepatitis C

May 02 2019

‘Extreme Outlier’ Vertex Slammed For Orkambi Pricing Approach In England

Mar 08 2019

Stand-Off: Vertex Refuses NICE Data on CF Drug Symkevi, HTA Body Awaits Next Move

Aug 14 2018

Related Companies

Vertex Pharmaceuticals Incorporated

Additional Topics

Europe United Kingdom Health Technology Assessment Market Access Policy Pricing Debate Rare Diseases Real-World Evidence Reimbursement BioPharmaceutical

More from Europe

More from Geography

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window